Mark Capone

Nephrosant, Inc. is a company dedicated to improving kidney health through noninvasive diagnostic tests. The company is based in Brisbane, CA. The company's flagship diagnostic test is QSant, a noninvasive urine-based test that supports early detection of kidney rejection risk. Nephrosant plans to develop centralized lab tests and point of care tests for kidney diseases and allograft monitoring for other organs. Founded in 2017 by Dr. Minnie Sarwal and UCSF physicians, the company has a team of world-class scientists, engineers, and clinicians who have licensed the founding team's clinical research to develop diagnostic tests for chronic kidney disease. Dr. Sarwal has been the CEO since 2017.

Precision Medicine Advisors LLC provides educational programs around genomic. The private company is based in New York. The American company was founded by Mark Christopher Capone and he has been the CEO since incorporation.

Owlstone Medical Ltd. develops breathalyzer device for use in clinical diagnostics and precision medicine with applications in cancer, inflammatory and infectious disease. The firm offers Lonestar VOC Analyzer, ReCIVA Breath Sampler and ultraFAIMS products. It also offers consult, analyze, and discover, report and validation services. The company was founded by Paul Boyle and Alonso David Ruiz in 2004 and is headquartered in Cambridge, CA.

Myriad Genetic Laboratories, Inc. provides cancer predisposition testing services. It operates as a biopharmaceutical company that focuses on developing therapeutic and predictive medicine products. The company was founded on October 11, 1995 and is headquartered in Salt Lake City, UT.